Acquisition agreement for DakoAcquisition Agreement • December 25th, 2022
Contract Type FiledDecember 25th, 2022Agilent, which paid $2.2 billion in cash for Dako (on a debt-free basis), expects the acquisition to help strengthen Agilent’s position in life sciences, with a focus on product development to help in the fight against cancer.